Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Industry groups agree MedPAC’s inflationary update is not enough

The Medicare Payment Advisory Commission (MedPAC) wants to tie physician payments to inflation. Healthcare groups say it doesn't go far enough

The American Medical Association (AMA) has declared climate change as a major healthcare emergency. Sunrises and sunsets have become increasingly red in recent years with additional particulate matter in the atmosphere from larger, massive wild fires. Photo by Dave Fornell

Bringing back the sabbatical: Radiologists offer 4 tips on how to make it happen

Two academic radiologists recently shared their experiences with taking extended time away from work in the hope that their story would encourage others to do the same. 

Thumbnail

Most US adults with medical debt owe hospitals

A significant portion of U.S. adults have some past-due medical debt, according to a recent study from the Urban Institute, and the majority of those with debt owe non-profit hospitals.

Medicare money payment physician

AMA pressures federal government to fix prior authorization problem plaguing radiology

About 89% of physicians surveyed believe that this payer tactic has had a negative impact on care, the association reported Monday. 

pain pills opioids

DOJ sues Rite Aid over role in opioid epidemic

According to the complaint, Rite Aid allegedly filled “at least” hundreds of thousands of unlawful prescriptions for controlled substances that lacked legitimate medical purpose, were not for a medically accepted indication or were not issued in the usual course of professional practice.

VA first to cover new ALZ drug

A new Alzheimer’s disease drug, Leqembi (lecanemab), will be covered by the Veterans Affairs for some patients, making the VA the first insurer to cover the drug.

Thumbnail

Pfizer to acquire Seagen for $43B

“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate technology with the scale and strength of Pfizer’s capabilities and expertise," says Pfizer Chairman and CEO Albert Bourla, PhD.

Thumbnail

Former CEO indicted for fake medical device implanted in patients

Laura Perryman, the former chief of Florida-based Stimwave, allegedly created a non-functioning “dummy device” that was used to treat patients suffering from chronic pain.